Company & Sponsor Intelligence

McMaster University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting3

Completed6

Countries1

Therapeutic footprint

adhdalzheimersdepressionocdpain_neuropathyptsdsubstance_use

Indexed studies

NCT05766241Investigating a Novel Sensory-based Program for Veterans With PTSD
ptsd · CanadaNA

NCT05314361Public Health Nurse-Delivered 1-Day CBT Workshops Pilot
depression · CanadaNA

NCT07050225Evaluating a Digital Cognitive Training Intervention in Adults With ADHD
adhd · NA

NCT05114187An Internet-Based Education Program for Care Partners of People Living With Dementia
alzheimers · CanadaNA

NCT00994786A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
ocd · CanadaPHASE4

NCT04954586Feasibility of Pain Informed Movement for Knee OA
pain_neuropathy · CanadaNA

NCT07671248Tirzepatide in the Treatment of Cannabis Use Disorder
substance_use · CanadaPHASE3

NCT00715858A Pilot Study of Inflammatory Markers in Alzheimer's Disease
alzheimers · CanadaPHASE3

NCT06597448Public Health Nurse-Peer Co-Led Group Cognitive Behavioral Therapy for Postpartum Depression
depression · CanadaNA

NCT03785223A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
adhd · CanadaPHASE4

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →